|
Anthony Sinskey, Ph.D. is a co-founder of Merrimack and has served on the Board of Directors since 1998. Dr. Sinskey is a Professor of Microbiology in the Department of Biology at MIT. He is widely recognized for pioneering multidisciplinary approaches to the metabolic engineering of industrially important organisms. Dr. Sinskey has helped to found many successful biotechnology companies including Genzyme and Aspen Technology. Dr. Sinskey is Co-Founder and member of the Board of Directors at Metabolix and a consultant to several fine chemicals and pharmaceuticals companies. Dr. Sinskey received a Sc.D. from MIT in 1966. | 